Form 4 for BMY Bristol Myers Squibb
Accepted 2021-07-06 00:00:00 ET · period of report 2021-07-01 · accession 0000014272-21-000182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-06 | 2021-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $66.56 | -4,786 | 11.8K | -29% | -$318.6K |
| D | 2021-07-06 | 2021-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,356 | 16.5K | +130% | $0 |
| D | 2021-07-06 | 2021-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | -9,356 | 18.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2021-07-01 | F | D | 4,786 | $66.56 | 11,752 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of restricted stock units. |
| 2 | Common | Common Stock, $0.10 par value | 2021-07-01 | M | A | 9,356 | $0.00 | 16,538 | D | — | — | (F1) The restricted stock unit vests in four equal installments beginning on July 1, 2020. |
| 3 | Derivative | Restricted Stock Units | 2021-07-01 | M | D | 9,356 | $0.00 | 18,713 | D | — · — to 2023-07-01 | 9,356 Common Stock, $0.10 par value | (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock unit vests in four equal installments beginning on July 1, 2020. |